Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials

Ähnliche Einträge

• The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial
  von: van Santen, D.K
  Veröffentlicht: (2021)
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
  von: Turner, K.M.E
  Veröffentlicht: (2011)
• HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C VIRUS TESTING SERVICES AT SYRINGE EXCHANGE PROGRAMS: AVAILABILITY AND OUTCOMES
  von: HEINZERLING, K.G
  Veröffentlicht: (2009)
• HEPATITIS C AND NEEDLE EXCHANGE
  von: ASHTON, M.
  Veröffentlicht: (2004)
• HEPATITIS C AND NEEDLE EXCHANGE (PART 4)
  von: ASHTON, M.
  Veröffentlicht: (2005)